Stay updated with breaking news from Davidt Doherty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Benchmark reissued their buy rating on shares of Surgery Partners (NASDAQ:SGRY – Free Report) in a research note published on Wednesday morning, Benzinga reports. They currently have a $50.00 target price on the stock. Other equities research analysts also recently issued research reports about the company. Citigroup decreased their price target on Surgery Partners from […]
Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Cantor Fitzgerald in a research note issued on Wednesday, Benzinga reports. They currently have a $43.00 price objective on the stock. Cantor Fitzgerald’s price objective points to a potential upside of 63.13% from the company’s previous close. Several […]
Clough Capital Partners L P lessened its holdings in Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) by 31.7% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 137,903 shares of the company’s stock after selling 63,900 shares during the period. Clough Capital Partners L P owned 0.11% […]
Landscape Capital Management L.L.C. purchased a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 9,649 shares of the company’s stock, valued at approximately $269,000. Several other institutional investors have also […]
Surgery Partners (NASDAQ:SGRY – Get Rating) had its price target boosted by Citigroup from $40.00 to $47.00 in a research report sent to investors on Tuesday, The Fly reports. Several other equities analysts have also recently issued reports on SGRY. JPMorgan Chase & Co. decreased their target price on shares of Surgery Partners from $45.00 […]